Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Filip Van den Bosch
Profile
Projects
Publications
Activities
Awards & Distinctions
298
Results
2024
ASAS consensus definition of early axial spondyloarthritis
Victoria Navarro-Compan
Diego Benavent
Dafne Capelusnik
Desiree van der Heijde
Robert B. M. Landewe
Denis Poddubnyy
Astrid van Tubergen
Xenofon Baraliakos
Filip Van den Bosch
Floris A. van Gaalen
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2024
Association of anatomical variants of the sacroiliac joint with bone marrow edema in patients with axial spondyloarthritis
Elke Vereecke
Lennart Jans
Nele Herregods
Min Chen
Jacob L. Jaremko
Frederiek Laloo
Philippe Carron
Gaëlle Varkas
Manouk de Hooge
Filip Van den Bosch
et al.
A1
Journal Article
in
SKELETAL RADIOLOGY
2024
Classification criteria for axial disease in youth with juvenile spondyloarthritis
Pamela F. Weiss
Timothy G. Brandon
Amita Aggarwal
Ruben Burgos‐Vargas
Robert A. Colbert
Gerd Horneff
Ronald M. Laxer
Kirsten Minden
Angelo Ravelli
Nicolino Ruperto
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update
Laure Gossec
Andreas Kerschbaumer
Ricardo J. O. Ferreira
Daniel Aletaha
Xenofon Baraliakos
Heidi Bertheussen
Wolf-Henning Boehncke
Bente Appel Esbensen
Iain B. Mcinnes
Dennis Mcgonagle
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2024
Efficacy and safety of risankizumab for active psoriatic arthritis : 100-week results from the KEEPsAKE 2 randomized clinical trial
Andrew Ostor
Filip Van den Bosch
Kim Papp
Cecilia Asnal
Ricardo Blanco
Jacob Aelion
Kyle Carter
Vassilis Stakias
Ralph Lippe
Leonidas Drogaris
et al.
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2024
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis
Martin Rudwaleit
Helena Marzo-Ortega
Victoria Navarro-Compan
Rachel Tham
Thomas Kumke
Lars Bauer
Natasha de Peyrecave
Mindy Kim
Filip Van den Bosch
A1
Journal Article
in
RMD OPEN
2024
Long-term efficacy and safety following switch between upadacitinib and adalimumab in patients with rheumatoid arthritis : 5-year data from SELECT-COMPARE
Roy Fleischmann
Ricardo Blanco
Filip Van den Bosch
Louis Bessette
Yanna Song
Sara K. Penn
Erin McDearmon-Blondell
Nasser Khan
Kelly Chan
Eduardo Mysler
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2024
Long-term safety of risankizumab in patients with psoriatic disease : a comprehensive analysis from clinical trials
Kenneth B. Gordon
Andrew Blauvelt
Herve Bachelez
Laura C. Coates
Filip Van den Bosch
Blair Kaplan
Willem Koetse
Doug G. Ashley
Ralph Lippe
Ranjeeta Sinvhal
et al.
A1
Journal Article
in
DERMATOLOGY AND THERAPY
2024
Maximal exercise tolerance, objective trunk strength, and mobility measurements in axial spondyloarthritis
Sophie De Mits
Tine Willems
Patrick Calders
Lieven Danneels
Gaëlle Varkas
Filip Van den Bosch
Dirk Elewaut
Philippe Carron
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2024
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial
U Kiltz
A Molto
C Lopez-Medina
M Dougados
D van der Heijde
A Boonen
Filip Van den Bosch
J Braun
A1
Journal Article
in
SEMINARS IN ARTHRITIS AND RHEUMATISM
2024
Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients
Manouk de Hooge
Alla Ischenko
Serge Steinfeld
Adrien Nzeusseu
Dirk Elewaut
Rik Lories
Filip Van den Bosch
Kurt De Vlam
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2024
Upadacitinib in active non-radiographic axial spondyloarthritis : 1-year data from a double-blind, randomized, placebo-controlled, phase 3 trial
Filip Van den Bosch
Atul Deodhar
Denis Poddubnyy
Walter P. Maksymowych
Desiree van der Heijde
Tae-Hwan Kim
Mitsumasa Kishimoto
Xenofon Baraliakos
Yihan Li
Kristin D'Silva
et al.
A2
Journal Article
in
ACR OPEN RHEUMATOLOGY
2024
Upadacitinib in rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs : efficacy and safety through 5 years (SELECT-NEXT)
Gerd R. Burmester
Filip Van den Bosch
John Tesser
Anna Shmagel
Yanxi Liu
Nasser Khan
Heidi S. Camp
Alan Kivitz
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2024
When usual care is not so usual : protocol violations and generalizability in a treat-to-target strategy trial in patients with axial spondyloarthritis
Clementina Lopez-Medina
Filip Van den Bosch
Desiree van Der Heijde
Maxime Dougados
Anna Molto
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2024
2023
ASAS-EULAR recommendations for the management of axial spondyloarthritis : 2022 update
Sofia Ramiro
Elena Nikiphorou
Alexandre Sepriano
Augusta Ortolan
Casper Webers
Xenofon Baraliakos
Robert B. M. Landewe
Filip Van den Bosch
Boryana Boteva
Ann Bremander
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Advances in primary Sjögren’s syndrome diagnosis and patient stratification : first results from the BeSSTT cohort
Liselotte Deroo
Dirk Elewaut
Isabelle Peene
Filip Van den Bosch
Dissertation
2023
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation
Ann-Sophie De Craemer
Torsten Witte
Triana Lobatón Ortega
Anne Hoorens
Martine De Vos
Claude Cuvelier
Sebastiaan J. Vastert
Xenofon Baraliakos
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
RHEUMATOLOGY
2023
Cardiovascular comorbidities in psoriatic arthritis : epidemiology and risk factors in two different European populations
Silvia Scriffignano
Rik Lories
Adrien Nzeusseu Toukap
Ennio Lubrano
Francesco Ciccia
Serge Steinfeld
Fabio Massimo Perrotta
Ilenia Pantano
Filip Van den Bosch
Kurt de Vlam
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Challenges of the unifying spondyloarthritis concept : insights from the clinical observational Be-GIANT cohort study
Ann-Sophie De Craemer
Dirk Elewaut
Filip Van den Bosch
Dissertation
2023
Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis
Koen Venken
Matthias Jarlborg
Tine Decruy
Céline Mortier
Carolien Vlieghe
Elisabeth Gilis
Ann-Sophie De Craemer
Julie Coudenys
Isabelle Cambré
Devan Fleury
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
Alen Zabotti
Gabriele De Marco
Laure Gossec
Xenofon Baraliakos
Daniel Aletaha
Annamaria Iagnocco
Paolo Gisondi
Peter Balint
Heidi Bertheussen
Wolf-Henning Boehncke
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Efficacy and safety of bimekizumab in axial spondyloarthritis : results of two parallel phase 3 randomised controlled trials
Desiree van der Heijde
Atul Deodhar
Xenofon Baraliakos
Matthew A. Brown
Hiroaki Dobashi
Maxime Dougados
Dirk Elewaut
Alicia M. Ellis
Carmen Fleurinck
Karl Gaffney
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Efficacy and safety of risankizumab for active psoriatic arthritis : 52-week results from the KEEPsAKE 2 study
Andrew Ostor
Filip Van den Bosch
Kim Papp
Cecilia Asnal
Ricardo Blanco
Jacob Aelion
Wenjing Lu
Zailong Wang
Ahmed M. Soliman
Ann Eldred
et al.
A1
Journal Article
in
RHEUMATOLOGY
2023
Etanercept withdrawal and retreatment in nonradiographic axial spondyloarthritis : results of RE-EMBARK, an open-label phase IV trial
Filip Van den Bosch
James Cheng-Chung Wei
Peter Nash
Francisco J. Blanco
Daniela Graham
Chuanbo Zang
Edmund Arthur
Cecilia Borlenghi
Vassilis Tsekouras
Bonnie Vlahos
et al.
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2023
Extent of axial damage in psoriatic arthritis and spondyloarthritis : comparative data from the BEPAS and (Be-)GIANT multicentre cohorts
Manouk de Hooge
Alla Ishchenko
Ann-Sophie De Craemer
Serge Steinfeld
Adrien Nzeusseu
Dirk Elewaut
Rik Lories
Kurt de Vlam
Filip Van den Bosch
A1
Journal Article
in
RMD OPEN
2023
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
Désirée van der Heijde
Anna Molto
Sofia Ramiro
Jürgen Braun
Maxime Dougados
Floris A van Gaalen
Lianne S Gensler
Robert D Inman
Robert B M Landewé
Helena Marzo-Ortega
et al.
Editorial material
2023
Gut inflammation in axial spondyloarthritis patients is characterized by a marked type 17 skewed mucosal innate‐like T cell signature
Céline Mortier
Katrien Quintelier
Ann-Sophie De Craemer
Thomas Renson
Liselotte Deroo
Emilie Dumas
Eveline Verheugen
Julie Coudenys
Tine Decruy
Zuzanna Łukasik
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2023
Machine learning pipeline for predicting bone marrow edema along the sacroiliac joints on magnetic resonance imaging
Joris Roels
Ann-Sophie De Craemer
Thomas Renson
Manouk de Hooge
Arne Gevaert
Thomas Van Den Berghe
Lennart Jans
Nele Herregods
Philippe Carron
Filip Van den Bosch
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2023
Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints : multicentre development and validation of diagnostic accuracy
Thomas Van Den Berghe
Danilo Babin
Min Chen
Martijn Callens
Denim Brack
Helena Maes
Jan Lievens
Marie Lammens
Maxime Van Sumere
Lieve Morbée
et al.
C3
Conference
2023
Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints : multicentre development and validation of diagnostic accuracy
Thomas Van Den Berghe
Danilo Babin
Min Chen
Martijn Callens
Denim Brack
Helena Maes
Jan Lievens
Marie Lammens
Maxime Van Sumere
Lieve Morbée
et al.
A1
Journal Article
in
EUROPEAN RADIOLOGY
2023
Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA : post-hoc analysis of the CRESPA trial
Simon Krabbe
Thomas Renson
Lennart Jans
Dirk Elewaut
Filip Van den Bosch
Philippe Carron
Mikkel Østergaard
A1
Journal Article
in
RHEUMATOLOGY
2023
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis : results at week 104 from a randomised placebo-controlled withdrawal study
Robert B. M. Landewe
Denis Poddubnyy
Proton Rahman
Filip Van den Bosch
Rebecca Bolce
Soyi Liu Leage
Jeffrey R. Lisse
So Young Park
Lianne Gensler
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response
Anna Molto
Desiree van der Heijde
Filip Van den Bosch
Maxime Dougados
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2023
Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
Juergen Braun
Ricardo Blanco
Helena Marzo-Ortega
Lianne S. Gensler
Filip Van den Bosch
Stephen Hall
Hideto Kameda
Denis Poddubnyy
Marleen van de Sande
Desiree van der Heijde
et al.
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2023
Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren’s syndrome
Liselotte Deroo
EVA GENBRUGGE
Frederick Dochy
David Creytens
Helena Achten
KRISTEL DE BOECK
WOUTER BAUTERS
Dimitri Roels
Joke Deprez
Filip Van den Bosch
et al.
A1
Journal Article
in
RHEUMATOLOGY
2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics : 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
Philip Mease
Arathi Setty
Kim Papp
Filip Van den Bosch
Shigeyoshi Tsuji
Mauro Keiserman
Kyle Carter
Yihan Li
Reva McCaskill
Erin McDearmon-Blondell
et al.
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Work participation is unaffected in Belgian spondyloarthritis patients : data from the Belgian Inflammatory Arthritis and Spondylitis Cohort
Ann-Sophie De Craemer
Liselotte Deroo
Thomas Renson
Ine Desimpele
Lauren Delmez
Saskia Decuman
Xavier Janssens
Annelies Boonen
Dirk Elewaut
Philippe Carron
et al.
A1
Journal Article
in
RHEUMATOLOGY
2023
2022
A machine learning pipeline for prediction of bone marrow oedema along the sacroiliac joints on magnetic resonance imaging
Joris Roels
Ann-Sophie De Craemer
Thomas Renson
Manouk de Hooge
Arne Gevaert
Lennart Jans
Nele Herregods
Thomas Van Den Berghe
Philippe Carron
Filip Van den Bosch
et al.
C3
Conference
2022
An AI-based algorithm for automatic detection of erosion and ankylosis on CT images of the sacroiliac joints : multicentre development and validation
Thomas Van Den Berghe
Min Chen
Danilo Babin
Nele Herregods
Wouter Huysse
Jacob Jaremko
Frederiek Laloo
Ann-Sophie De Craemer
Philippe Carron
Filip Van den Bosch
et al.
C3
Conference
2022
An AI-based algorithm for automatic detection of erosion and ankylosis on CT images of the sacroiliac joints : multicentre development and validation
Thomas Van Den Berghe
Min Chen
Danilo Babin
Nele Herregods
Wouter Huysse
Jacob Jaremko
Frederiek Laloo
Ann-Sophie De Craemer
Philippe Carron
Filip Van den Bosch
et al.
C3
Conference
2022
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations
Felicie Costantino
Philippe Aegerter
Georg Schett
Ann-Sophie De Craemer
Anna Molto
Filip Van den Bosch
Dirk Elewaut
Maxime Breban
Maria-Antonietta D'agostino
A1
Journal Article
in
RHEUMATOLOGY
2022
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
Uta Kiltz
Annelies Boonen
Désirée van der Heijde
Wilson Bautista-Molano
Ruben Burgos Vargas
Praveena Chiowchanwisawakit
Bassel El-Zorkany
Inna Gaydukova
Pal Geher
Laure Gossec
et al.
A1
Journal Article
in
RHEUMATOLOGY
2022
Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome
Liselotte Deroo
Helena Achten
Kristel De Boeck
Eva Genbrugge
WOUTER BAUTERS
Dimitri Roels
Frederick Dochy
David Creytens
Ann-Sophie De Craemer
Filip Van den Bosch
et al.
A1
Journal Article
in
SEMINARS IN ARTHRITIS AND RHEUMATISM
2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis : results from a phase III, randomised, double-blind, placebo-controlled trial
Victoria Navarro-Compan
James Cheng-Chung Wei
Filip Van den Bosch
Marina Magrey
Lisy Wang
Dona Fleishaker
Joseph C. Cappelleri
Cunshan Wang
Joseph Wu
Oluwaseyi Dina
et al.
A1
Journal Article
in
RMD OPEN
2022
Efficacy and safety of risankizumab for active psoriatic arthritis : 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
Andrew Ostor
Filip Van den Bosch
Kim Papp
Cecilia Asnal
Ricardo Blanco
Jacob Aelion
Gabriela Alperovich
Wenjing Lu
Zailong Wang
Ahmed M. Soliman
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2022
Improving the design of RCTs in non-radiographic axial spondyloarthritis
Walter P. Maksymowych
Robert G. W. Lambert
Liron Caplan
Filip Van den Bosch
Mikkel ostergaard
A1
Journal Article
in
NATURE REVIEWS RHEUMATOLOGY
2022
Neural network based algorithm pipeline for automatic detection of erosions and ankylosis of the sacroiliac joints : development and validation using multicentre CT images
Thomas Van Den Berghe
Min Chen
Danilo Babin
Nele Herregods
Wouter Huysse
Jacob Jaremko
Frederiek Laloo
Ann-Sophie De Craemer
Philippe Carron
Filip Van den Bosch
et al.
C3
Conference
2022
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis
Ann-Sophie De Craemer
Thomas Renson
Liselotte Deroo
Liesbet Van Praet
Heleen Cypers
Gaëlle Varkas
Rik Joos
Mieke Devinck
Lieve Gyselbrecht
Isabelle Peene
et al.
A1
Journal Article
in
RHEUMATOLOGY
2022
Progressive increase in sacroiliac joint and spinal lesions detected on magnetic resonance imaging in healthy individuals in relation to age
Thomas Renson
Manouk de Hooge
Ann-Sophie De Craemer
Liselotte Deroo
Zuzanna Łukasik
Philippe Carron
Nele Herregods
Lennart Jans
Roos Colman
Filip Van den Bosch
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2022
Real-world efficacy and safety of apremilast in Belgian patients with psoriatic arthritis : results from the prospective observational APOLO study
Kurt de Vlam
Adrien Nzeusseu Toukap
Marie-Joelle Kaiser
Johan Vanhoof
Philip Remans
Marthe Van den Berghe
Silvana Di Romana
Filip Van den Bosch
Rik Lories
A1
Journal Article
in
ADVANCES IN THERAPY
2022
Response to : ‘Finding the right one’ by Zanwar
Thomas Renson
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2022
Safety and efficacy of upadacitinib in patients with active ankylosing spondylitis and an inadequate response to nonsteroidal antiinflammatory drug therapy : one-year results of a double-blind, placebo-controlled study and open-label extension
A Deodhar
D van der Heijde
J Sieper
Filip Van den Bosch
WP Maksymowych
TH Kim
M Kishimoto
A Ostor
B Combe
Y Sui
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2022
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome
Liselotte Deroo
Helena Achten
Kristel De Boeck
Eva Genbrugge
Wouter Bauters
Dimitri Roels
Frederick Dochy
David Creytens
Joke Deprez
Filip Van den Bosch
et al.
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial
Atul Deodhar
Filip Van den Bosch
Denis Poddubnyy
Walter P Maksymowych
Désirée van der Heijde
Tae-Hwan Kim
Mitsumasa Kishimoto
Ricardo Blanco
Yuanyuan Duan
Yihan Li
et al.
A1
Journal Article
in
LANCET
2022
Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
Desiree van der Heijde
Atul Deodhar
Walter P. Maksymowych
Joachim Sieper
Filip Van den Bosch
Tae-Hwan Kim
Mitsumasa Kishimoto
Andrew J. Ostor
Bernard Combe
Yunxia Sui
et al.
A1
Journal Article
in
RMD OPEN
2022
2021
Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies
Xenofon Baraliakos
Filip Van den Bosch
Pedro M. Machado
Lianne S. Gensler
Helena Marzo-Ortega
Bintu Sherif
Erhard Quebe-Fehling
Brian Porter
Corine Gaillez
Atul Deodhar
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2021
Axial involvement in patients with early peripheral spondyloarthritis : a prospective MRI study of sacroiliac joints and spine
Thomas Renson
Philippe Carron
Ann-Sophie De Craemer
Liselotte Deroo
Manouk de Hooge
Simon Krabbe
Lennart Jans
Min Chen
Mikkel Ostergaard
Filip Van den Bosch
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
Axial involvement in psoriatic arthritis : an update for rheumatologists
Denis Poddubnyy
Deepak R. Jadon
Filip Van den Bosch
Philip J. Mease
Dafna D. Gladman
A1
Journal Article
in
SEMINARS IN ARTHRITIS AND RHEUMATISM
2021
Axial involvement in psoriatic arthritis cohort (AXIS) : the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Denis Poddubnyy
Xenofon Baraliakos
Filip Van den Bosch
Jurgen Braun
Laura C. Coates
Vinod Chandran
Torsten Diekhoff
Floris A. van Gaalen
Lianne S. Gensler
Niti Goel
et al.
A1
Journal Article
in
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
2021
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission : efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
Robert B. M. Landewé
Lianne S. Gensler
Denis Poddubnyy
Proton Rahman
Maja Hojnik
Xiaoqi Li
Soyi Liu Leage
David Adams
Hilde Carlier
Filip Van den Bosch
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Anna Molto
Clementina López-Medina
Filip Van den Bosch
Annelies Boonen
Casper Webers
Emanuelle Dernis
Floris A van Gaalen
Martin Soubrier
Pascal Claudepierre
Athan Baillet
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
FRI0304 serum IGG-undergalactosylation profiles reflect cumulative exposure to systemic inflammation in spondyloarthritis patients
Ann-Sophie De Craemer
Z. Lukasik
L. Meuris
Liselotte Deroo
Thomas Renson
Manouk de Hooge
Philippe Carron
Annelies Van Hecke
Nico Callewaert
Filip Van den Bosch
et al.
C3
Conference
2021
FRI0312 anti-CD74 IGA antibodies are most sensitive and specific to identify young male axial spondyloarthritis patients
Ann-Sophie De Craemer
T. Witte
Liselotte Deroo
Thomas Renson
Philippe Carron
Filip Van den Bosch
X. Baraliakos
Dirk Elewaut
C3
Conference
2021
IL-23 and axial disease : do they come together?
Philip Mease
Filip Van den Bosch
A1
Journal Article
in
RHEUMATOLOGY
2021
Identifying pitfalls and opportunities of magnetic resonance imaging in spondyloarthritis
Thomas Renson
Dirk Elewaut
Filip Van den Bosch
Joke Dehoorne
Dissertation
2021
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies
Uta Kiltz
James Cheng-Chung Wei
Desiree van der Heijde
Filip Van den Bosch
Jessica A. Walsh
Annelies Boonen
Lianne S. Gensler
Theresa Hunter
Hilde Carlier
Yan Dong
et al.
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2021
MRI-based synthetic CT in the detection of structural lesions in patients with suspected sacroiliitis : comparison with MRI
Lennart Jans
Min Chen
Dirk Elewaut
Filip Van den Bosch
Philippe Carron
Peggy Jacques
Ruth Wittoek
Jacob L. Jaremko
Nele Herregods
A1
Journal Article
in
RADIOLOGY
2021
Measuring treatment effect on psoriatic arthritis-related domains : insights from the SPIRIT-H2H study at weeks 24 and 52
Frank Behrens
Soyi Liu Leage
Christophe Sapin
Celine El Baou
Inmaculada De la Torre
Gabriella Meszaros
Georg Schett
Bernard Combe
Filip Van den Bosch
Laure Gossec
A1
Journal Article
in
CLINICAL RHEUMATOLOGY
2021
Patient-reported outcomes in psoriatic arthritis patients with an inadequate response to biologic disease-modifying antirheumatic drugs : SELECT-PsA 2
Vibeke Strand
Filip Van den Bosch
Roberto Ranza
Ying-Ying Leung
Edit Drescher
Patrick Zueger
Christopher D. Saffore
Apinya Lertratanakul
Ralph Lippe
Peter Nash
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2021
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement
Peter Nash
Andreas Kerschbaumer
Thomas Doerner
Maxime Dougados
Roy M. Fleischmann
Klaus Geissler
Iain McInnes
Janet E. Pope
Desiree van der Heijde
Michaela Stoffer-Marx
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
SAT0549 a semi-quantitative MRI scoring system for inflammation in joints and entheses in the lower extremities demonstrates good reliability and validity : post-hoc analysis of data from the crespa trial
S. Krabbe
Thomas Renson
Lennart Jans
Dirk Elewaut
Filip Van den Bosch
Philippe Carron
M. Ǿstergaard
C3
Conference
2021
Secukinumab efficacy on enthesitis in patients with ankylosing spondylitis : pooled analysis of four pivotal phase III studies
Georg Schett
Xenofon Baraliakos
Filip Van den Bosch
Atul Deodhar
Mikkel Ostergaard
Ayan Das Gupta
Shephard Mpofu
Todd Fox
Adam Winseck
Brian Porter
et al.
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2021
Secukinumab in non-radiographic axial spondyloarthritis : subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
Jurgen Braun
Ricardo Blanco
Helena Marzo-Ortega
Lianne S. Gensler
Filip Van den Bosch
Stephen Hall
Hideto Kameda
Denis Poddubnyy
Marleen van de Sande
Anna S. Wiksten
et al.
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2021
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response : efficacy and safety in patients with rheumatoid arthritis
Roy M. Fleischmann
Ricardo Blanco
Stephen Hall
Glen T. D. Thomson
Filip Van den Bosch
Cristiano Zerbini
Louis Bessette
Jeffrey Enejosa
Yihan Li
Yanna Song
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
TNFi-induced sustained clinical remission in peripheral spondyloarthritis patients cannot be maintained with a step-down strategy based on methotrexate
Philippe Carron
Ann-Sophie De Craemer
Thomas Renson
Roos Colman
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
RHEUMATOLOGY
2021
The burden of psoriatic arthritis in the biologics era : data from the Belgian Epidemiological Psoriatic Arthritis Study
Kurt de Vlam
Serge Steinfeld
Adrien Nzeusseu Toukap
Filip Van den Bosch
Rik Joos
Piet Geysens
Hermine Leroi
Rik Lories
A1
Journal Article
in
RHEUMATOLOGY
2021
The value of magnetic resonance imaging for assessing disease extent and prediction of relapse in early peripheral spondyloarthritis
Thomas Renson
Philippe Carron
Ann-Sophie De Craemer
Liselotte Deroo
Manouk de Hooge
Simon Krabbe
Lennart Jans
Mikkel Østergaard
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2021
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis
Sophie De Mits
Ann-Sophie De Craemer
Liselotte Deroo
Thomas Renson
Filip Van den Bosch
Philippe Carron
Dirk Elewaut
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
Upadacitinib for psoriatic arthritis refractory to biologics : SELECT-PsA 2
Philip J. Mease
Apinya Lertratanakul
Jaclyn K. Anderson
Kim Papp
Filip Van den Bosch
Shigeyoshi Tsuji
Eva Dokoupilova
Mauro Keiserman
Xin Wang
Sheng Zhong
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2021
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics : 56-week data from the randomized controlled phase 3 SELECT-PsA 2 study
Philip J. Mease
Apinya Lertratanakul
Kim A. Papp
Filip Van den Bosch
Shigeyoshi Tsuji
Eva Dokoupilova
Mauro W. Keiserman
Xianwei Bu
Liang Chen
Reva M. McCaskill
et al.
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2021
2020
Bone marrow edema detection using dual-energy CT : application in sacroiliitis
Min Chen
Jacob Jaremko
Filip Van den Bosch
Nele Herregods
Philippe Carron
Dirk Elewaut
Lennart Jans
C3
Conference
2020
Bone marrow edema in sacroiliitis : detection with dual-energy CT
Min Chen
Nele Herregods
Jacob Jaremko
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Lennart Jans
A1
Journal Article
in
EUROPEAN RADIOLOGY
2020
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
Uta Kiltz
Robert B. M. Landewe
Desiree van der Heijde
Martin Rudwaleit
Michael H. Weisman
Nurullah Akkoc
Annelies Boonen
Jan Brandt
Philippe Carron
Maxime Dougados
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
Diagnostic performance for erosion detection in sacroiliac joints on MR T1-weighted images : comparison between different slice thicknesses
Min Chen
Nele Herregods
Jacob L. Jaremko
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Lennart Jans
A1
Journal Article
in
EUROPEAN JOURNAL OF RADIOLOGY
2020
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update
Laure Gossec
Xenofon Baraliakos
Andreas Kerschbaumer
Maarten de Wit
Iain McInnes
Maxime Dougados
Jette Primdahl
Dennis G. McGonagle
Daniel Aletaha
Andra Balanescu
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Maxime Dougados
James Cheng-Chung Wei
Robert Landewe
Joachim Sieper
Xenofon Baraliakos
Filip Van den Bosch
Walter P. Maksymowych
Joerg Ermann
Jessica A. Walsh
Tetsuya Tomita
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
High prevalence of spondyloarthritis-like MRI lesions in postpartum women : a prospective analysis in relation to maternal, child and birth characteristics
Thomas Renson
Anaïs Depicker
Ann-Sophie De Craemer
Liselotte Deroo
Gaëlle Varkas
Manouk de Hooge
Philippe Carron
Lennart Jans
Nele Herregods
Isabelle Dehaene
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
Immunoscintigraphy in axial spondyloarthritis : a new imaging modality for sacroiliac inflammation
Philippe Carron
Thomas Renson
Manouk de Hooge
Bieke Lambert
Kathia De Man
Lennart Jans
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment : 48-week outcomes from C-OPTIMISE
Robert Landewe
Desiree van der Heijde
Maxime Dougados
Xenofon Baraliakos
Filip Van den Bosch
Karl Gaffney
Lars Bauer
Bengt Hoepken
Natasha de Peyrecave
Karen Thomas
et al.
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2020
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Robert B. M. Landewe
Desiree van der Heijde
Maxime Dougados
Xenofon Baraliakos
Filip Van den Bosch
Karl Gaffney
Lars Bauer
Bengt Hoepken
Owen R. Davies
Natasha de Peyrecave
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2020
Peripheral spondyloarthritis : a neglected entity-state of the art
Philippe Carron
Ann-Sophie De Craemer
Filip Van den Bosch
A1
Journal Article
in
RMD OPEN
2020
Revisiting the gut-joint axis : links between gut inflammation and spondyloarthritis
Eric Gracey
Lars Vereecke
Dermot McGovern
Mareike Fröhling
Georg Schett
Silvio Danese
Martine De Vos
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
NATURE REVIEWS RHEUMATOLOGY
2020
Serum IGG-Undergalactosylation profiles reflect cumulative exposure to systemic inflammation in Spondyloarthritis patients
A. S. De Craemer
Z. Lukasik
Leander Meuris
L. Deroo
T. Renson
Manouk de Hooge
P. Carron
Annelies Van Hecke
Nico Callewaert
Filip Van den Bosch
et al.
C3
Conference
2020
Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis : results from the ASAS-COMOSPA study
Carmen Stolwijk
Ivette Essers
Filip Van den Bosch
Maxime Dougados
Adrien Etcheto
Désirée van der Heijde
Robert Landewé
Anna Molto
Astrid van Tubergen
Annelies Boonen
A1
Journal Article
in
RHEUMATOLOGY
2020
2019
A practical guide to interpret MRI features of new bone formation in axial spondyloarthritis
Frederiek Laloo
Nele Herregods
Jacob Jaremko
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Koenraad Verstraete
Lennart Jans
C3
Conference
2019
AxSpA patients with symptom onset < 30 years have more structural lesions on MRI of the sacroiliac joints when fulfilling the modified new york criteria
Manouk de Hooge
Ann-Sophie De Craemer
Thomas Renson
Philippe Carron
Liselotte Deroo
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2019
Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population : the QUO-VADIS study
Filip Van den Bosch
RM Flipo
J Braun
N Vastesaeger
S Kachroo
M Govoni
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2019
Clinical features of axial spondyloarthritis patients diagnosed in peripheral versus an academic hospital
Ann-Sophie De Craemer
Thomas Renson
Philippe Carron
Peggy Jacques
Jan Lenaerts
Lieve Gyselbrecht
Rik Joos
Filip Van den Bosch
Dirk Elewaut
[missing] Be-Giant consortium
C3
Conference
2019
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis : two-year results of CareRA
Veerle Stouten
Rene Westhovens
Sofia Pazmino
Diederik De Cock
Kristien Van der Elst
Johan Joly
Patrick Verschueren
on behalf of the CareRA study group
Filip Van den Bosch
A1
Journal Article
in
RHEUMATOLOGY
2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1) : a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Desiree van der Heijde
In-Ho Song
Aileen L Pangan
Atul Deodhar
Filip Van den Bosch
Walter P Maksymowych
Tae-Hwan Kim
Mitsumasa Kishimoto
Andrea Everding
Yunxia Sui
et al.
A1
Journal Article
in
LANCET
2019
Erosions are the most often reported structural lesion on MRI of the sacroiliac joints in axspa patients with IBP
Manouk de Hooge
Ann-Sophie De Craemer
Thomas Renson
Philippe Carron
Liselotte Deroo
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2019
Expert consensus : practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies
Gaëlle Varkas
Clio Ribbens
Edouard Louis
Filip Van den Bosch
Rik Lories
Severine Vermeire
Dirk Elewaut
Martine De Vos
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2019
Gender contrasts in patient reported outcomes don’t alter the disease activity score in axial spondyloarthritis patients
Ann-Sophie De Craemer
Thomas Renson
Liselotte Deroo
Manouk de Hooge
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
[missing] Be-Giant consortium
C3
Conference
2019
High prevalence of sacroiliac bone marrow edema on MRI in post partum women : a temporary phenomenom
Thomas Renson
Ann-Sophie De Craemer
Liselotte Deroo
Anaïs Depicker
Manouk de Hooge
Nele Herregods
Lennart Jans
Kristien Roelens
Isabelle Dehaene
Philippe Carron
et al.
C3
Conference
2019
High prevalence of sacroiliac bone marrow edema on MRI in postpartum women : a temporary phenomenon
Thomas Renson
Ann-Sophie De Craemer
Anaïs Depicker
Liselotte Deroo
Manouk de Hooge
Nele Herregods
Lennart Jans
Gaëlle Varkas
Kristien Roelens
Isabelle Dehaene
et al.
C3
Conference
2019
Ileal but not colonic inflammation is linked to fatty lesions on MRI of the sacroiliac joints in spondyloarthritis patients
Ann-Sophie De Craemer
Manouk de Hooge
Thomas Renson
Liselotte Deroo
Triana Lobatón Ortega
Anne Hoorens
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
[missing] Be-Giant consortium
C3
Conference
2019
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis : 5-year results from the phase III MEASURE 1 extension study
Xenofon Baraliakos
Juergen Braun
Atul Deodhar
Denis Poddubnyy
Alan Kivitz
Hasan Tahir
Filip Van den Bosch
Evie-Maria Delicha
Zsolt Talloczy
Anke Fierlinger
A1
Journal Article
in
RMD OPEN
2019
Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe : confirmation of findings from a German cohort study
Manouk de Hooge
Floris A van Gaalen
Thomas Renson
Ann-Sophie De Craemer
Marleen G van de Sande
Roberta Ramonda
Karen Minde Fagerli
Lennart TH Jacobsson
Desiree van der Heijde
Dirk Elewaut
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2019
MRI lesions in the sacroiliac joints of patients with spondyloarthritis : an update of definitions and validation by the ASAS MRI working group
Walter P Maksymowych
Robert GW Lambert
Mikkel Ostergaard
Susanne Juhl Pedersen
Pedro M Machado
Ulrich Weber
Alexander N Bennett
Juergen Braun
Ruben Burgos-Vargas
Manouk de Hooge
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2019
MRI of the axial skeleton in spondyloarthritis : the many faces of new bone formation
Frederiek Laloo
Nele Herregods
Jacob L Jaremko
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Koenraad Verstraete
Lennart Jans
A1
Journal Article
in
INSIGHTS INTO IMAGING
2019
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
Koen Venken
Peggy Jacques
Céline Mortier
Mark E. Labadia
Tine Decruy
Julie Coudenys
Kathleen Hoyt
Anita L. Wayne
Robert Hughes
Michael Turner
et al.
A1
Journal Article
in
NATURE COMMUNICATIONS
2019
Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.
Lennart Jans
Isabelle De Kock
Nele Herregods
Koenraad Verstraete
Filip Van den Bosch
Philippe Carron
Edwin H Oei
Dirk Elewaut
Peggy Jacques
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2019
Spinal mobility in spondyloarthritis patients : do the BASMI-measurements correlate with the David Back devices-measurements?
Sophie De Mits
Liselotte Deroo
Ann-Sophie De Craemer
Thomas Renson
Tine Willems
Lieven Danneels
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
C3
Conference
2019
The course of aberrant findings on MRI of the sacroiliac joints over 6 months in postpartum women
Anaïs Depicker
Thomas Renson
Ann-Sophie De Craemer
Manouk de Hooge
Liselotte Deroo
Gaëlle Varkas
Nele Herregods
Lennart Jans
Kristien Roelens
Isabelle Dehaene
et al.
C3
Conference
2019
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort
Pascal Claudepierre
Filip Van den Bosch
Piercarlo Sarzi-Puttini
Nathan Vastesaeger
Marinella Govoni
Sumesh Kachroo
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
2019
Trunk strength and spinal mobility in spondyloarthritis patients
Sophie De Mits
Liselotte Deroo
Ann-Sophie De Craemer
Thomas Renson
Tine Willems
Lieven Danneels
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
C3
Conference
2019
Trunk strength and spinal mobility in spondyloarthritis patients
Tine Willems
Lieven Danneels
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
Sophie De Mits
C3
Conference
2019
2018
Association of comorbidities in spondyloarthritis with poor function, work disability and quality of life : results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis study
E Nikiphorou
S Ramiro
D van der Heijde
S Norton
A Moltó
M Dougados
Filip Van den Bosch
R Landewé
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2018
Association of inflammatory bowel disease and acute anterior uveitis, but not psoriasis, with disease duration in patients with axial spondyloarthritis : results from two Belgian nationwide axial spondyloarthritis cohorts
Gaëlle Varkas
Nathan Vastesaeger
Heleen Cypers
Roos Colman
Thomas Renson
Liesbet Van Praet
Philippe Carron
Frank Raeman
Mieke Devinck
Lieve Gyselbrecht
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2018
Axial spondyloarthritis : new insights in diagnosis and patient stratification
Gaëlle Varkas
Dirk Elewaut
Filip Van den Bosch
Dissertation
2018
Clinical management of psoriatic arthritis
Filip Van den Bosch
Laura Coates
A1
Journal Article
in
LANCET
2018
Dual-energy CT : a new imaging modality for bone marrow oedema in rheumatoid arthritis
Lennart Jans
Isabelle De Kock
Nele Herregods
Koenraad Verstraete
Filip Van den Bosch
Philippe Carron
Edwin H Oei
Dirk Elewaut
Peggy Jacques
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
Effect of mechanical stress on magnetic resonance imaging of the sacroiliac joints : assessment of military recruits by magnetic resonance imaging study
Gaëlle Varkas
Manouk de Hooge
Thomas Renson
Sophie De Mits
Philippe Carron
Peggy Jacques
Muriel Moris
Geert Souverijns
Lennart Jans
Dirk Elewaut
et al.
A1
Journal Article
in
RHEUMATOLOGY
2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR) : results from a randomised, placebo-controlled, phase 2 trial
Philip Mease
Laura C Coates
Philip S Helliwell
Mykola Stanislavchuk
Anna Rychlewska-Hanczewska
Anna Dudek
Walid Abi-Saab
Chantal Tasset
Luc Meuleners
Pille Harrison
et al.
A1
Journal Article
in
LANCET
2018
High rate of drug-free remission after induction therapy with golimumab in early peripheral spondyloarthritis
Philippe Carron
Gaëlle Varkas
Thomas Renson
Roos Colman
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2018
Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study
Ruth Wittoek
Philippe Carron
Bieke Lambert
Paulien Meersseman
August Verbruggen
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
Inequity in biological DMARD prescription for spondyloarthritis across the globe : results from the ASAS-COMOSPA study
Elena Nikiphorou
Desiree van der Heijde
Sam Norton
Robert BM Landewe
Anna Molto
Maxime Dougados
Filip Van den Bosch
Sofia Ramiro
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V) : 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Desiree van der Heijde
James Cheng-Chung Wei
Maxime Dougados
Philip Mease
Atul Deodhar
Walter P. Maksymowych
Filip Van den Bosch
Joachim Sieper
Tetsuya Tomita
Robert Landewe
et al.
A1
Journal Article
in
LANCET
2018
Measurement properties of the ASAS Health Index : results of a global study in patients with axial and peripheral spondyloarthritis
Uta Kiltz
Desiree van der Heijde
Annelies Boonen
Nurullah Akkoc
Wilson Bautista-Molano
Ruben Burgos-Vargas
James Cheng-Chung Wei
Praveena Chiowchanwisawakit
Maxime Dougados
M Tuncay Duruoz
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
New bone formation in the intervertebral joint space in spondyloarthritis : an MRI study
Frederiek Laloo
Nele Herregods
Jacob L Jaremko
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Koenraad Verstraete
Lennart Jans
A1
Journal Article
in
EUROPEAN JOURNAL OF RADIOLOGY
2018
New imaging modalities and treatment strategies in spondyloarthritis
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
Dissertation
2018
Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America : a comparative study with the general population and data from the ASAS-COMOSPA study
Wilson Bautista-Molano
Robert Landewé
Rubén Burgos-Vargas
José Maldonado-Cocco
Anna Moltó
Filip Van den Bosch
Rafael Valle-Oñate
Maxime Dougados
Désirée van der Heijde
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2018
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT) : a randomised, double-blind, placebo-controlled phase 3 trial
Gerd R Burmester
Joel M Kremer
Filip Van den Bosch
Alan Kivitz
Louis Bessette
Yihan Li
Yijie Zhou
Ahmed A Othman
Aileen L Pangan
Heidi S Camp
A1
Journal Article
in
LANCET
2018
Sick leave and its predictors in ankylosing spondylitis : long-term results from the Outcome in Ankylosing Spondylitis International Study
Casper Webers
Sofia Ramiro
Robert Landewe
Desiree van der Heijde
Filip Van den Bosch
Maxime Dougados
Astrid van Tubergen
Annelies Boonen
A1
Journal Article
in
RMD OPEN
2018
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target : 2017 update of recommendations by an international task force
Josef S Smolen
Monika Schoels
Juergen Braun
Maxime Dougados
Oliver FitzGerald
Dafna D Gladman
Arthur Kavanaugh
Robert Landewe
Philip Mease
Joachim Sieper
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
Uncovering the heterogeneity of disease impact in axial spondyloarthritis : bivariate trajectories of disease activity and quality of life
Maike Imkamp
Valeria Lima Passos
Annelies Boonen
Suzanne Arends
Maxime Dougados
Robert Landewe
Sofia Ramiro
Filip Van den Bosch
Desiree van der Heijde
Freke R. Wink
et al.
A1
Journal Article
in
RMD OPEN
2018
Work participation in spondyloarthritis across countries : analysis from the ASAS-COMOSPA study
Santiago Rodrigues Manica
Alexandre Sepriano
Sofia Ramiro
Fernando Pimentel Santos
Polina Putrik
Elena Nikiphorou
Sam Norton
Anna Molto
Maxime Dougados
Desiree van der Heijde
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2018
2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Désirée van der Heijde
Sofia Ramiro
Robert Landewé
Xenofon Baraliakos
Filip Van den Bosch
Alexandre Sepriano
Andrea Regel
Adrian Ciurea
Hanne Dagfinrud
Maxime Dougados
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2017
ASAS definition for sacroiliitis on MRI in SpA : applicable to children?
Nele Herregods
Jo Dehoorne
Filip Van den Bosch
Jacob Lester Jaremko
Joke Van Vlaenderen
Rik Joos
Xenofon Baraliakos
Gaëlle Varkas
Koenraad Verstraete
Dirk Elewaut
et al.
A1
Journal Article
in
PEDIATRIC RHEUMATOLOGY
2017
An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease : a case series
Gaëlle Varkas
Kristof Thevissen
G De Brabanter
Liesbet Van Praet
F Czul-gurdian
Heleen Cypers
JORIS DE KOCK
Philippe Carron
Martine De Vos
Pieter Hindryckx
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2017
Anti-TNF-induced remission in very early peripheral spondyloarthritis : the CRESPA study
Philippe Carron
Gaëlle Varkas
Heleen Cypers
Liesbet Van Praet
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2017
Dialister as a microbial marker of disease activity in spondyloarthritis
Raul Y. Tito
Heleen Cypers
Marie JOOSSENS
Gaëlle Varkas
Liesbet Van Praet
ELIEN GLORIEUS
Filip Van den Bosch
Martine De Vos
Jeroen Raes
Dirk Elewaut
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2017
Effects of long-term etanercept treatment on clinical outcomes and objective signs of inflammation in early nonradiographic axial spondyloarthritis : 104-week results from a randomized, placebo-controlled study
Maxime Dougados
Désirée van der Heijde
Joachim Sieper
Jürgen Braun
Gustavo Citera
Jan Lenaerts
Filip Van den Bosch
James Cheng-Chung Wei
Ron Pedersen
Randi Bonin
et al.
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2017
Efficacy and safety of biological and targeted-synthetic DMARDs : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Alexandre Sepriano
Andrea Regel
Désirée van der Heijde
Jürgen Braun
Xenofon Baraliakos
Robert Landewé
Filip Van den Bosch
Louise Falzon
Sofia Ramiro
A2
Journal Article
in
RMD OPEN
2017
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Andrea Regel
Alexandre Sepriano
Xenofon Baraliakos
Désirée van der Heijde
Jürgen Braun
Robert Landewé
Filip Van den Bosch
Louise Falzon
Sofia Ramiro
A2
Journal Article
in
RMD OPEN
2017
Impact of participation in the Adalimumab (Humira) patient support program on rheumatoid arthritis treatment course : results from the PASSION study
Filip Van den Bosch
Andrew JK Ostor
Siegfried Wassenberg
Naijun Chen
Chen Wang
Vishvas Garg
Jasmina Kalabic
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2017
MR signal in the sacroiliac joint space in spondyloarthritis : a new sign
Frederiek Laloo
Nele Herregods
Gaëlle Varkas
JL Jaremko
X Baraliakos
Dirk Elewaut
Filip Van den Bosch
Koenraad Verstraete
Lennart Jans
A1
Journal Article
in
EUROPEAN RADIOLOGY
2017
Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with adalimumab
Philip J Mease
Filip Van den Bosch
Joachim Sieper
Yinglin Xia
Aileen L Pangan
In-Ho Song
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2017
Presence of bone marrow edema and structural lesions on magnetic resonance imaging of the sacroiliac joints in young military recruits before and after 6 weeks of intensive physical training
Gaëlle Varkas
Manouk de Hooge
Thomas Renson
Sophie De Mits
Philippe Carron
Peggy Jacques
Muriel Moris
Geert Souverijns
Lennart Jans
Dirk Elewaut
et al.
C3
Conference
2017
Presence of bone marrow edema on magnetic resonance imaging of the sacroiliac joints in military recruits before and after 6 weeks of intensive physical training
Gaëlle Varkas
Manouk de Hooge
Thomas Renson
Philippe Carron
Sophie De Mits
G Souverijns
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2017
Prevalence of structural lesions typical for axial spondyloarthritis in young military recruits before and after mechanical stress
Gaëlle Varkas
Manouk deHooge
Thomas Renson
Philippe Carron
Sophie De Mits
G Souverijns
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2017
Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando et al
Gaëlle Varkas
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2017
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis : results from a randomised phase III trial (FUTURE 1)
Vibeke Strand
Philip Mease
Laure Gossec
Ori Elkayam
Filip Van den Bosch
James Zuazo
Luminita Pricop
Shephard Mpofu
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2017
Secukinumab in active rheumatoid arthritis after anti-TNFα therapy : a randomized, double-blind placebo-controlled phase 3 study
Hasan Tahir
Atul Deodhar
Mark Genovese
Tsutomu Takeuchi
Jacob Aelion
Filip Van den Bosch
Sibylle Haemmerle
Hanno B Richards
A1
Journal Article
in
RHEUMATOLOGY AND THERAPY
2017
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis : 4-year outcomes from RAPID-axSpA
Désirée van der Heijde
Maxime Dougados
Robert Landewé
Joachim Sieper
Walter P Maksymowych
Martin Rudwaleit
Filip Van den Bosch
Jürgen Braun
Philip J Mease
Alan J Kivitz
et al.
A1
Journal Article
in
RHEUMATOLOGY
2017
The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study
Pauline Bakker
Anna Moltó
Adrien Etcheto
Filip Van den Bosch
Robert Landewé
Floris van Gaalen
Maxime Dougados
Désirée van der Heijde
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2017
The role of intestinal inflammation in initiation, monitoring and outcome of spondyloarthritis
Heleen Cypers
Dirk Elewaut
Filip Van den Bosch
Dissertation
2017
Whipple’s disease in granulomatous disguise : a challenging diagnosis with many histopathological pitfalls
Mieke Van Bockstal
Anne Hoorens
Filip Van den Bosch
David Creytens
Sofie Verbeke
Jo Van Dorpe
A1
Journal Article
in
VIRCHOWS ARCHIV
2017
2016
99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study
Bieke Lambert
Philippe Carron
Yves D'Asseler
Klaus Bacher
Filip Van den Bosch
Dirk Elewaut
August Verbruggen
Rudi Beyaert
Caroline Dumolyn
Filip De Vos
A1
Journal Article
in
EJNMMI RESEARCH
2016
A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis : results of the PALACE 2 trial
Maurizio Cutolo
Gary E. Myerson
Roy M. Fleischmann
Frederic Liote
Federico Diaz-Gonzalez
Filip Van den Bosch
Helena Marzo-Ortega
Eugen Feist
Kamal Shah
ChiaChi Hu
et al.
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2016
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis
Michael M Ward
Atul Deodhar
Elie A Akl
Andrew Lui
Joerg Ermann
Lianne S Gensler
Judith A Smith
David Borenstein
Jayme Hiratzka
Pamela F Weiss
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2016
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis
Michael M Ward
Atul Deodhar
Elie A Akl
Andrew Lui
Joerg Ermann
Lianne S Gensler
Judith A Smith
David Borenstein
Jayme Hiratzka
Pamela F Weiss
et al.
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2016
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study
Walter P Maksymowych
Maxime Dougados
Désirée van der Heijde
Joachim Sieper
Jürgen Braun
Gustavo Citera
Filip Van den Bosch
Isabelle Logeart
Joseph Wajdula
Heather Jones
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC) : long-term extension over 7 years with focus on clinical efficacy and safety
F Heldmann
X Baraliakos
U Kiltz
J Brandt
IE van der Horst-Bruinsma
R Landewé
J Sieper
GR Burmester
Filip Van den Bosch
K de Vlam
et al.
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2016
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis : update by the ASAS MRI working group
Robert GW Lambert
Pauline AC Bakker
Désirée van der Heijde
Ulrich Weber
Martin Rudwaleit
Kay-Geert A Hermann
Joachim Sieper
Xenofon Baraliakos
Alex Bennett
Jürgen Braun
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2016
Do extra-articular manifestations influence outcome in ankylosing spondylitis? : 12-year results from OASIS
I Essers
S Ramiro
C Stolwijk
M Blaauw
R Landewé
D van der Heijde
Filip Van den Bosch
M Dougados
A van Tubergen
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2016
Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
Heleen Cypers
Gaëlle Varkas
Sam Beeckman
Karlijn Debusschere
T Vogl
J Roth
Michael Drennan
M Lavric
D Foell
Claude Cuvelier
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2016
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies : 2015 update
L Gossec
JS Smolen
S Ramiro
M de Wit
M Cutolo
M Dougados
P Emery
R Landewé
S Oliver
D Aletaha
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2016
Gender-attributable differences in outcome of ankylosing spondylitis : long-term results from the Outcome in Ankylosing Spondylitis International Study
Casper Webers
Ivette Essers
Sofia Ramiro
Carmen Stolwijk
Robert Landewé
Désirée van der Heijde
Filip Van den Bosch
Maxime Dougados
Astrid van Tubergen
A1
Journal Article
in
RHEUMATOLOGY
2016
Long-term efficiency of infliximab in patients with ankylosing spondylitis : real life data confirm the potential for dose reduction
X Baraliakos
F Heldmann
Filip Van den Bosch
G Burmester
H Gaston
IE van der Horst-Bruinsma
A Krause
R Schmidt
M Schneider
J Sieper
et al.
A2
Journal Article
in
RMD OPEN
2016
Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages
U Kiltz
D van der Heijde
A Boonen
W Bautista-Molano
R Burgos-Vargas
P Chiowchanwisawakit
T Duruoz
B El-Zorkany
I Essers
I Gaydukova
et al.
A2
Journal Article
in
RMD OPEN
2016
NSAIDs in axial spondyloarthritis : to be continued…?
Gaëlle Varkas
Filip Van den Bosch
Editorial material
2016
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort : a final analysis
Alexandre Sepriano
Robert Landewé
Désirée van der Heijde
Joachim Sieper
Nurullah Akkoc
Jan Brandt
Jürgen Braun
Eduardo Collantes-Estevez
Maxime Dougados
Oliver Fitzgerald
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2016
Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis
Philippe Carron
Bieke Lambert
Liesbet Van Praet
Filip De Vos
Gaëlle Varkas
Lennart Jans
Dirk Elewaut
Filip Van den Bosch
A2
Journal Article
in
RMD OPEN
2016
Six-week treatment of axial spondyloarthritis patients with an optimal dose of nonsteroidal antiinflammatory drugs : early response to treatment in signal intensity on magnetic resonance imaging of the sacroiliac joints
Gaëlle Varkas
Lennart Jans
Heleen Cypers
Liesbet Van Praet
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2016
Work outcome in patients with ankylosing spondylitis : results from a 12-year followup of an international study
JD Castillo-Ortiz
S Ramiro
R Landewé
D van der Heijde
M Dougados
Filip Van den Bosch
A Boonen
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2016
2015
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
Ivette Essers
Sofia Ramiro
Carmen Stolwijk
Marc Blaauw
Robert Landewé
Désirée van der Heijde
Filip Van den Bosch
Maxime Dougados
Astrid van Tubergen
A1
Journal Article
in
RHEUMATOLOGY
2015
Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations
Filip Van den Bosch
Arthur Kavanaugh
Martina Kron
Hartmut Kupper
Philip J Mease
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2015
Diagnositic value of pelvic enthesitis on MRI of the sacroiliac joints in enthesitis related arthritis
Nele Herregods
Jo Dehoorne
EVA PATTYN
J. L. Jaremko
X. Baraliakos
Dirk Elewaut
J Van Vlaenderen
Filip Van den Bosch
R Joos
Koenraad Verstraete
et al.
A1
Journal Article
in
PEDIATRIC RHEUMATOLOGY
2015
Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis
Nele Herregods
Jo Dehoorne
Rik Joos
Jacob L Jaremko
Xenofon Barailakos
ASTRID LEUS
Filip Van den Bosch
Koenraad Verstraete
Lennart Jans
A1
Journal Article
in
CLINICAL RADIOLOGY
2015
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
Sofia Ramiro
Carmen Stolwijk
Astrid van Tubergen
Désirée van der Heijde
Maxime Dougados
Filip Van den Bosch
Robert Landewé
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2015
Hierarchy of impairment of spinal mobility measures in ankylosing spondylitis: twelve-year data
Sofia Ramiro
Robert BM Landewé
Désirée van der Heijde
Carmen Stolwijk
Maxime Dougados
Filip Van den Bosch
Astrid van Tubergen
A1
Journal Article
in
ARTHRITIS CARE & RESEARCH
2015
Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis : a longitudinal analysis
Sofia Ramiro
Robert Landewe
Astrid van Tubergen
Annelies Boonen
Carmen Stolwijk
Maxime Dougados
Filip Van den Bosch
Desiree van der Heijde
A2
Journal Article
in
RMD OPEN
2015
Outcome-based anti-TNFα treatment decisions in rheumatoid arthritis and axial spondyloarthritis : facilitating physician's and payer's choices
Nathan Vastesaeger
Filip Van den Bosch
Dirk Elewaut
Dissertation
2015
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis : results of the international cross-sectional ASAS-COMOSPA study
Anna Moltó
Adrien Etcheto
Désirée van der Heijde
Robert Landewé
Filip Van den Bosch
Wilson Bautista Molano
Ruben Burgos-Vargas
Peter P Cheung
Eduardo Collantes-Estevez
Atul Deodhar
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2015
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis
Philip Mease
Joachim Sieper
Filip Van den Bosch
Proton Rahman
P Mahinda Karunaratne
Aileen L Pangan
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2015
Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis
Philip J Mease
Iain B McInnes
Bruce Kirkham
Arthur Kavanaugh
Proton Rahman
Désirée van der Heijde
Robert Landewé
Peter Nash
Luminita Pricop
Jiacheng Yuan
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2015
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis
Dominique Baeten
Joachim Sieper
Jürgen Braun
Xenofon Baraliakos
Maxime Dougados
Paul Emery
Atul Deodhar
Brian Porter
Ruvie Martin
Mats Andersson
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2015
2014
A physically demanding job may amplify the effect of disease activity on the development of syndesmophytes in patients with ankylosing spondylitis
Sofia Ramiro
AM van Tubergen
Robert Landewé
Annelies Boonen
Carmen Stolwijk
Maxime Dougados
Filip Van den Bosch
Désirée van der Heijde
C3
Conference
2014
Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis
Carmen Stolwijk
Astrid van Tubergen
Sofia Ramiro
Ivette Essers
Marc Blaauw
Désirée van der Heijde
Robert Landewé
Filip Van den Bosch
Maxime Dougados
Annelies Boonen
A1
Journal Article
in
RHEUMATOLOGY
2014
Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients
Philippe Carron
Bieke Lambert
Filip De Vos
August Verbruggen
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2014
Better performance of the Leeds and Sparcc enthesitis indices compared to the mases in patients with peripheral spondyloarthritis during treatment with adalimumab
Philip Mease
Filip Van den Bosch
Joachim Sieper
Aileen L Pangan
Nupun A Varothai
In-Ho Song
C3
Conference
2014
Calgranulin levels are elevated in spondyloarthritis and reflect the presence of acute microscopic gut inflammation
Heleen Cypers
Gaëlle Varkas
Liesbet Van Praet
Johannes Roth
Thomas Vogl
Claude Cuvelier
Dirk Föll
Miha Lavric
Filip Van den Bosch
Dirk Elewaut
C3
Conference
2014
Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort
Liesbet Van Praet
Lennart Jans
Philippe Carron
Peggy Jacques
ELIEN GLORIEUS
Roos Colman
Heleen Cypers
Herman Mielants
Martine De Vos
Claude Cuvelier
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2014
Diagnostic value of pelvic enthesitis on MRI of the sacroiliac joints in spondyloarthritis
Lennart Jans
Charlotte Van Langenhove
Liesbet Van Praet
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
VALERIE LAMBRECHT
Jacob L Jaremko
Koenraad Verstraete
A1
Journal Article
in
EUROPEAN RADIOLOGY
2014
Do extra-articular manifestations influence outcome in ankylosing spondylitis?: a 12 year follow-up study
Ivette Essers
Sofia Ramiro
Carmen Stolwijk
Marc Blaauw
Robert Landewé
Désirée M van der Heijde
Filip Van den Bosch
Maxime Dougados
Astrid van Tubergen
C3
Conference
2014
Dose optimization of infliximab in patients with rheumatoid arthritis
Rieke Alten
Filip Van den Bosch
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
2014
Erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis
Sofia Ramiro
Astrid van Tubergen
Désirée van der Heijde
Carmen Stolwijk
Gideon Bookelman
Maxime Dougados
Filip Van den Bosch
Robert BM Landewé
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2014
Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the outcome in ankylosing spondylitis international study
Casper Webers
Ivette Essers
Sofia Ramiro
Carmen Stolwijk
Robert Landewé
Désirée van der Heijde
Filip Van den Bosch
Maxime Dougados
Astrid van Tubergen
C3
Conference
2014
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
Sofia Ramiro
Désirée van der Heijde
Astrid van Tubergen
Carmen Stolwijk
Maxime Dougados
Filip Van den Bosch
Robert Landewé
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2014
How sensitive and specific are MRI features of sacroiliitis for diagnosis of spondyloarthritis in patients with inflammatory back pain?
Lennart Jans
Laurent Coeman
Liesbet Van Praet
Philippe Carron
Dirk Elewaut
Filip Van den Bosch
Jacob L Jaremko
Wouter Huysse
Koenraad Verstraete
A1
Journal Article
in
JBR-BTR
2014
How to deal with missing items in BASDAI and BASFI
Sofia Ramiro
Astrid van Tubergen
Désirée van der Heijde
Filip Van den Bosch
Maxime Dougados
Robert Landewé
A1
Journal Article
in
RHEUMATOLOGY
2014
MRI of the SI joints commonly shows non-inflammatory disease in patients clinically suspected of sacroiliitis
Lennart Jans
Liesbet Van Praet
Dirk Elewaut
Filip Van den Bosch
Philippe Carron
Jacob L Jaremko
Maxim Behaeghe
Alexander Denis
Wouter Huysse
VALERIE LAMBRECHT
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF RADIOLOGY
2014
Sustained clinical remission in patients with non-radiographic axial spondyloarthritis after two years of adalimumab treatment
Joachim Sieper
Dominique L Baeten
Filip Van den Bosch
Suchitrita S Rathmann
Jaclyn Anderson
Aileen L Pangan
C3
Conference
2014
The concept of axial spondyloarthritis
Atul Deodhar
John D Reveille
Filip Van den Bosch
Jürgen Braun
Ruben Burgos-Vargas
Liron Caplan
Daniel O Clegg
Robert A Colbert
Lianne S Gensler
Désirée van der Heijde
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATOLOGY
2014
The concept of spondyloarthritis: where are we now?
Neha Garg
Filip Van den Bosch
Atul Deodhar
A1
Journal Article
in
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
2014
Tofacitinib versus methotrexate in rheumatoid arthritis
Eun Bong Lee
Roy Fleischmann
Stephen Hall
Bethanie Wilkinson
John D Bradley
David Gruben
Tamas Koncz
Sriram Krishnaswami
Gene V Wallenstein
Chuanbo Zang
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2014
Translation and cross-cultural adaptation of the ASAS Health Index and the environmental Item Set into 15 languages
Uta Kiltz
Désirée van der Heijde
Annelies Boonen
Wilson Bautista-Molano
Ruben Burgos-Vargas
Praveena Chiowchanwisawakit
M Tuncay Duruoz
Bassel El-Zorkany
Inna Gaydukova
Ivette Essers
et al.
C3
Conference
2014
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S Smolen
Jürgen Braun
Maxime Dougados
Paul Emery
Oliver FitzGerald
Philip Helliwell
Arthur Kavanaugh
Tore K Kvien
Robert Landewé
Thomas Luger
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2014
Treatment of spondyloarthritis beyond TNF-alpha blockade
Filip Van den Bosch
Atul Deodhar
A1
Journal Article
in
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
2014
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents?: a long-term observational study using MRI and conventional radiography
X Baraliakos
F Heldmann
J Callhoff
J Listing
T Appelboom
J Brandt
Filip Van den Bosch
M Breban
GR Burmester
M Dougados
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2014
2013
99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study
Bieke Lambert
Philippe Carron
Yves D'Asseler
Klaus Bacher
Filip Van den Bosch
Lennart Jans
Dirk Elewaut
August Verbruggen
Filip De Vos
C3
Conference
2013
Emerging therapies for rheumatoid arthritis
Peggy Jacques
Filip Van den Bosch
A1
Journal Article
in
EXPERT OPINION ON EMERGING DRUGS
2013
Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
Liesbet Van Praet
Filip Van den Bosch
Peggy Jacques
Philippe Carron
Lennart Jans
Roos Colman
ELIEN GLORIEUS
Harald Peeters
Herman Mielants
Martine De Vos
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2013
Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis
Philippe Carron
Bieke Lambert
Filip De Vos
August Verbruggen
Dirk Elewaut
Filip Van den Bosch
C3
Conference
2013
Selecting patients with spondyloarthritis (SpA) or rheumatoid arthritis (RA) for antiTNF-alfa treatment: first scintigraphic data with Tc99m-labelled certolizumab pegol
Philippe Carron
Bieke Lambert
Filip Van den Bosch
Dirk Elewaut
August Verbruggen
Lennart Jans
Yves D'Asseler
Filip De Vos
C3
Conference
2013
2012
A conundrum: classifying patients with SpA in daily practice
Filip Van den Bosch
Dirk Elewaut
Editorial material
2012
Pathophysiology and role of the gastrointestinal system in spondyloarthritides
Peggy Jacques
Liesbet Van Praet
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
2012
Peripheral manifestations in spondyloarthritis: relevance for diagnosis, classification and follow-up
Philippe Carron
Liesbet Van Praet
Filip Van den Bosch
A1
Journal Article
in
CURRENT OPINION IN RHEUMATOLOGY
2012
Synovial fluid derived iNKT cells in chronic arthritides show an increased PROGRAMMED DEATH-1 expression and anergic phenotype
Koen Venken
Lode Melis
Peggy Jacques
Liesbet Van Praet
Filip Van den Bosch
Dirk Elewaut
C3
Conference
2012
The transition of acute to chronic bowel inflammation in spondyloarthritis
Liesbet Van Praet
Peggy Jacques
Filip Van den Bosch
Dirk Elewaut
A1
Journal Article
in
NATURE REVIEWS RHEUMATOLOGY
2012
Therapy for spondyloarthritis : the role of extra-articular manifestations (eye, skin)
Philippe Carron
Liesbet Van Praet
Peggy Jacques
Dirk Elewaut
Filip Van den Bosch
A1
Journal Article
in
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
2012
2011
Mucosal inflammation in spondylarthritides : past, present, and future
Liesbet Van Praet
Filip Van den Bosch
Herman Mielants
Dirk Elewaut
A1
Journal Article
in
CURRENT RHEUMATOLOGY REPORTS
2011
The European Ankylosing Spondylitis Infliximab Cohort (EASIC) : a European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
F Heldmann
J Brandt
IE van der Horst-Bruinsma
R Landewe
J Sieper
GR Burmester
Filip Van den Bosch
K de Vlam
P Geusens
H Gaston
et al.
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2011
The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M Rudwaleit
D van der Heijde
R Landewé
N Akkoc
J Brandt
CT Chou
M Dougados
F Huang
J Gu
Y Kirazli
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2011
2010
A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations
Filip Van den Bosch
A1
Journal Article
in
CLINICAL RHEUMATOLOGY
2010
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
Martin Rudwaleit
Filip Van den Bosch
Martina Kron
Sonja Kary
Hartmut Kupper
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2010
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions
Filip Van den Bosch
B Manger
P Goupille
N McHugh
E Rodevand
P Holck
RF van Vollenhoven
M Leirisalo-Repo
O FitzGerald
M Kron
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2010
Efficacy and safety of Infliximab in patients with active spondyloarthritis: results of a long-term follow-up study
MIEKE DEVINCK
Philippe Carron
Herman Mielants
Filip Van den Bosch
C3
Conference
2010
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
Robert BM Landewé
Jos GA Houbiers
Filip Van den Bosch
Joanna in't Hout
Patrick CPM Verschueren
Jan H Meijerink
Frank HJ van den Hoogen
Bedrich A Masek
George AW Bruyn
Jacques MGW Wouters
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2010
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis a phase I randomized, double-blind, placebo-controlled, proof-of-concept study
MC Genovese
Filip Van den Bosch
SA Roberson
S Bojin
IM Biagini
Peter Ryan
J Sloan-Lancaster
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2010
Reduced levels of the TGFB family member GDF15 in spondyloarthritis versus other rheumatic diseases
Stijn Lambrecht
Filip Van den Bosch
Bert Vander Cruyssen
Filip De Keyser
August Verbruggen
Dieter Deforce
Dirk Elewaut
C3
Conference
2010
2009
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
D. van der Heijde
E. Lie
T. K. Kvien
J. Sieper
Filip Van den Bosch
J. Listing
J. Braun
R. Landewe
Philippe Carron
Manouk de Hooge
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2009
Adalimumab for long-term treatment of psoriatic arthritis : 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
P. J. Mease
P. Ory
J. T. Sharp
C. T. Ritchlin
Filip Van den Bosch
F. Wellborne
C. Birbara
G. T. D. Thomson
R. J. Perdok
J. Medich
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2009
Clinical Observations programme in SpA: disease parameters, treatment options and practical management issues
Dirk Elewaut
Filip Van den Bosch
August Verbruggen
Filip De Keyser
Bert Vander Cruyssen
Herman Mielants
A1
Journal Article
in
Rheumatology International
2009
Etanercept in the longterm treatment of patients with ankylosing spondylitis
Ben Dijkmans
Paul Emery
Markku Hakala
Marjatta Leirisalo-Repo
Emilio Martin Mola
Laurence Paolozzi
Carlo Salvarani
Jean Sibilia
Joachim Sieper
Filip Van den Bosch
et al.
A1
Journal Article
in
Journal of Rheumatology
2009
Extra-articular manifestations
Herman Mielants
Filip Van den Bosch
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2009
Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with Infliximab
Juergen Braun
Desiree van der Heijde
Mittie Doyle
Chenglong Han
Atul Deodhar
Robert Inman
Kurt de Vlam
Gerd Burmester
Filip Van den Bosch
Stephen Xu
et al.
A1
Journal Article
in
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
2009
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
Katrien Van Beneden
Ken Coppieters
W Laroy
Filip De Keyser
Ilse Hoffman
Filip Van den Bosch
Bert Vander Cruyssen
Michael Drennan
Peggy Jacques
P Rottiers
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2009
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome
Annelies Boonen
Bert Vander Cruyssen
Kurt de Vlam
Serge Steinfeld
Clio Ribbens
Jan Lenaerts
Filip Van den Bosch
Lode Dewulf
Nathan Vastesaeger
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2009
2008
Agreement between evidence and Belgian rheumatologists' experience on HLA B27 determination in patients with specific imaging features in ankylosing spondylitis
Ruth Wittoek
Kurt De Vlam
R FRANCOIS
L GOTLIEB
J LENAERTS
Filip Van den Bosch
Herman Mielants
C3
Conference
2008
Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis
Ruth Wittoek
Kurt De Vlam
R FRANCOIS
L GOTLIEB
J LENAERTS
Filip Van den Bosch
Herman Mielants
C3
Conference
2008
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst
Danielle M. Gerlag
Luba Lopatinskaya
L. Klareskog
M. D. Smith
Filip Van den Bosch
Huib J. Dinant
Yih Lee
Timothy Wyant
Eric W. Jacobson
et al.
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2008
Spontaneous amelioration in early RA: Role of antibody profiles in predicting decrease of disease activity
Bert Vander Cruyssen
AMM MILTENBURG
Filip Van den Bosch
J HOUBIERS
Ruth Wittoek
AMH BOOTS
Filip De Keyser
C3
Conference
2008
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
Bert Vander Cruyssen
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
L VERBRUGGEN
L DEWULF
et al.
C3
Conference
2008
2007
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip
FP LUYTEN
P GEUSENS
M MALAISE
L DE CLERCK
R WESTHOVENS
F RAEMAN
D VANDER MIJNSBRUGGE
L MATHY
JP HAUZEUR
Filip De Keyser
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2007
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo
BERT VANDER CRUYSSEN
Filip De Keyser
ELLI KRUITHOF
Herman Mielants
Filip Van den Bosch
Editorial material
2007
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: Role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity
BERT VANDER CRUYSSEN
AMM MILTENBURG
Filip Van den Bosch
JGA HOUBIERS
Ruth Wittoek
AMH BOOTS
Filip De Keyser
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2007
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
Bert Vander Cruyssen
Clio Ribbens
Annelies Boonen
Herman Mielants
Kurt De Vlam
Jan Lenaerts
Serge Steinfeld
Filip Van den Bosch
Lode Dewulf
Nathan Vastesaeger
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2007
2006
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman
Danielle M. Gerlag
Tom J. M. Smeets
Dominique Baeten
Filip Van den Bosch
Barry Bresnihan
Ferdinand C. Breedveld
Huib J. Dinant
Francois Legay
Hermann Gram
et al.
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2006
Anti-TNF-alpha therapy in ankylosing spondylitis
Filip De Keyser
Filip Van den Bosch
Herman Mielants
A1
Journal Article
in
CYTOKINE
2006
Clinical assessment in the spondyloarthropathies, including psoriatic arthritis
Filip Van den Bosch
Bert Vander Cruyssen
Herman Mielants
A1
Journal Article
in
CURRENT OPINION IN RHEUMATOLOGY
2006
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
Bert Vander Cruyssen
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
L VERBRUGGEN
N VASTESAEGER
et al.
C3
Conference
2006
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
Bert Vander Cruyssen
Stijn Van Looy
Bart Wyns
R WESTHOVENS
P DUREZ
Filip Van den Bosch
Herman Mielants
L DE CLERCK
A PERETZ
M MALAISE
et al.
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2006
Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
Stijn Van Looy
Bert Vander Cruyssen
Jeroen Meeus
Bart Wyns
R WESTHOVENS
P DUREZ
Filip Van den Bosch
N VASTESAEGER
A GELDHOF
Luc Boullart
et al.
A1
Journal Article
in
ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE
2006
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis
Dominique Baeten
J HOUBIERS
ELLI KRUITHOF
Bernard Vandooren
Filip Van den Bosch
AM BOOTS
Eric Veys
AMM MILTENBURG
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2006
Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice?
Bert Vander Cruyssen
Herman Mielants
A BOONEN
J LENAERTS
E LESAFFRE
Kurt De Vlam
C RIBBENS
S STEINFELD
Filip Van den Bosch
N VASTESAEGER
et al.
C3
Conference
2006
2005
5-year safety and efficacy follow-up in 107 spondyloarthropathy patients with continued long-term infliximab treatment
Filip Van den Bosch
MIEKE DEVINCK
Elli Kruithof
G VERBRUGGEN
Filip De Keyser
Herman Mielants
Eric Veys
C3
Conference
2005
Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
Bert Vander Cruyssen
Stijn Van Looy
R WESTHOVENS
P DUREZ
Filip Van den Bosch
EM VEYS
L DE CLERCK
A PERETZ
M MALAISE
J DEVOGELAER
et al.
C3
Conference
2005
Effective immunomodulation of peripheral joint pathology in spondyloarthropathy by etanercept
Elli Kruithof
Leen De Rycke
J ROTH
Herman Mielants
Filip Van den Bosch
Filip De Keyser
Eric Veys
Dominique Baeten
C3
Conference
2005
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
Elli Kruithof
Dominique Baeten
Filip Van den Bosch
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2005
IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications
Leen De Rycke
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
Eric Veys
Filip De Keyser
C3
Conference
2005
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
Elli Kruithof
Leen De Rycke
J ROTH
Herman Mielants
Filip Van den Bosch
Filip De Keyser
Eric Veys
Dominique Baeten
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2005
Impact of natural changes in disease activity on synovial histopathology in rheumatoid arthritis
Dominique Baeten
J HOUBIERS
Elli Kruithof
Bernard Vandooren
Filip Van den Bosch
A BOOTS
Eric Veys
A MILTENBURG
Filip De Keyser
C3
Conference
2005
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity : biologic and clinical implications in autoimmune arthritis
Leen De Rycke
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
Eric Veys
Filip De Keyser
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2005
Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years
Filip Van den Bosch
MIEKE DEVINCK
Elli Kruithof
Ilse Hoffman
G VERBRUGGEN
Filip De Keyser
Herman Mielants
Eric Veys
C3
Conference
2005
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
Leen De Rycke
Xavier Verhelst
Elli Kruithof
Filip Van den Bosch
Ilse Hoffman
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2005
Short and long term synovial immunumodulation by etanercept in spondyloarthropathy
Elli Kruithof
Leen De Rycke
Filip Van den Bosch
Herman Mielants
Eric Veys
Filip De Keyser
Dominique Baeten
C3
Conference
2005
The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications
Leen De Rycke
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
Eric Veys
Filip De Keyser
A1
Journal Article
in
LUPUS
2005
Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
Filip Van den Bosch
Filip De Keyser
Herman Mielants
Eric Veys
A1
Journal Article
in
ARTHRITIS RESEARCH & THERAPY
2005
2004
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
JR KIRWAN
R HALLGREN
Herman Mielants
F WOLLHEIM
E BJORCK
T PERSSON
C BOOK
S BOWMAN
M BYRON
N COX
et al.
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2004
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy
Bernard Vandooren
Elli Kruithof
DTY YU
M RIHL
JR GU
Leen De Rycke
Filip Van den Bosch
Eric Veys
Filip De Keyser
Dominique Baeten
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in Ankylosing spondylitis
Filip De Keyser
Dominique Baeten
Filip Van den Bosch
ELLI KRUITHOF
G VERBRUGGEN
Herman Mielants
E VEYS
A1
Journal Article
in
DRUGS
2004
The effect of infliximab on skin lesions in a patient with scleroderma (CREST)
Leen De Rycke
Dominique Baeten
Filip Van den Bosch
Herman Mielants
Filip De Keyser
Eric Veys
C3
Conference
2004
The lunar achilles as a screening tool for osteoporosis: Comparison with spine DXA
S PORIAU
P GEUSENS
Filip Van den Bosch
Filip De Keyser
C3
Conference
2004
2003
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
Leen De Rycke
Elli Kruithof
Nancy Van Damme
Ilse Hoffman
N VAN DEN BOSSCHE
Filip Van den Bosch
Eric Veys
Filip De Keyser
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2003
Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
Leen De Rycke
Elli Kruithof
Nancy Van Damme
Ilse Hoffman
Filip Van den Bosch
Eric Veys
Filip De Keyser
C3
Conference
2003
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety and biological immunomodulation
Filip De Keyser
Dominique Baeten
Filip Van den Bosch
Elli Kruithof
Herman Mielants
Eric Veys
A2
Journal Article
in
Rheumatic diseases Clin. N. Am.
2003
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation
Filip De Keyser
Dominique Baeten
Filip Van den Bosch
Elli Kruithof
Herman Mielants
Eric Veys
A1
Journal Article
in
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
2003
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
N VAN DEN BOSSCHE
A HERSSENS
Herman Mielants
Filip De Keyser
Eric Veys
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2003
Systematic safety follow-up in a cohort of 107 patients with spondylarthropathy treated with Infliximab: a new perspective of the role of host defence in the pathogenesis of the disease?
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
N VAN DEN BOSSCHE
Marianne Herssens
Herman Mielants
Filip De Keyser
Eric Veys
A2
Journal Article
in
Annals of Rheumatic Diseases
2003
2002
Costimulatory blockade in patients with rheumatoid arthritis a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
LW MORELAND
R ALTEN
Filip Van den Bosch
T APPELBOOM
M LEON
P EMERY
S COHEN
M LUGGEN
W SHERGY
I NUAMAH
et al.
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2002
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis : effects of treatment with cyclosporin A (Neoral®)
Ann VanderBorght
Filip De Keyser
Piet Geusens
Marc De Backer
Michel Malaise
Dominique Baeten
Filip Van den Bosch
Eric Veys
Jef Raus
Piet Stinissen
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
Filip Van den Bosch
Elli Kruithof
Dominique Baeten
Annemie Herssens
Filip De Keyser
Herman Mielants
Eric Veys
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2002
Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up
Elli Kruithof
Filip Van den Bosch
Dominique Baeten
A Herssens
Filip De Keyser
Herman Mielants
Eric Veys
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2002
Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis
Elli Kruithof
Philippe Kestelyn
C Elewaut
Dirk Elewaut
Filip Van den Bosch
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2002
2001
Characteristic macro- and microscopic aspect of the synovial membrane in crystal induced arthritis
Filip Van den Bosch
Dominique Baeten
Elli Kruithof
Filip De Keyser
Eric Veys
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
2001
Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply.
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2001
Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study
Dominique Baeten
Elli Kruithof
Filip Van den Bosch
Pieter Demetter
Nancy Van Damme
Claude Cuvelier
Martine De Vos
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ARTHRITIS AND RHEUMATISM
2001
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
Dominique Baeten
Nancy Van Damme
Filip Van den Bosch
Elli Kruithof
Martine De Vos
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2001
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.
Filip Van den Bosch
Dominique Baeten
Elli Kruithof
Filip De Keyser
Herman Mielants
Eric Veys
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2001
2000
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
P EMERY
FC BREEDVELD
EM LEMMEL
JP KALTWASSER
PT DAWES
B GOMOR
Filip Van den Bosch
D NORDSTROM
O BJORNEBOE
R DAHL
et al.
A1
Journal Article
in
RHEUMATOLOGY
2000
Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration
Dirk Elewaut
Filip De Keyser
Filip Van den Bosch
August Verbruggen
Eric Veys
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2000
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity
Dominique Baeten
Pieter Demetter
Claude Cuvelier
Filip Van den Bosch
Elli Kruithof
Nancy Van Damme
August Verbruggen
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2000
Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.
Filip Van den Bosch
Elli Kruithof
Martine De Vos
Filip De Keyser
Herman Mielants
A1
Journal Article
in
LANCET
2000
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
Filip Van den Bosch
Elli Kruithof
Dominique Baeten
Filip De Keyser
Herman Mielants
Eric Veys
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2000
1999
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients
Dominique Baeten
Filip Van den Bosch
Dirk Elewaut
A Stuer
Eric Veys
Filip De Keyser
A1
Journal Article
in
CLINICAL RHEUMATOLOGY
1999
1998
Enrichment of T cells carrying 137 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis
Dirk Elewaut
Filip De Keyser
Filip Van den Bosch
AI Lazarovits
Martine De Vos
Claude Cuvelier
August Verbruggen
Herman Mielants
Eric Veys
A1
Journal Article
in
JOURNAL OF RHEUMATOLOGY
1998